Answers are grounded in this paper and cite their sources.
Observational analysis shows improved thyroid hormones and glucose-lipid metabolism in hyperthyroidism patients, indicating benefits of health promotion interventions.
Objective: To investigate the effects of a Health Promotion Model (HPM)-based comprehensive intervention on thyroid hormones, glucose-lipid metabolism, and inflammatory markers in patients with hyperthyroidism (HT) complicated by diabetes mellitus (DM), and to elucidate the potential mechanisms underlying these effects. Methods: A total of 142 patients diagnosed with HT and DM between January 2024 and January 2025 were enrolled. Participants were divided into two groups: the HPM group (n=64), which received a structured HPM-based intervention, and the conventional group (n=78), which underwent standard management. Laboratory assessments were conducted before and after the intervention to evaluate thyroid hormones (FT3, FT4, TSH), glucose-lipid metabolism parameters (fasting plasma glucose [FPG], glycated hemoglobin [HbA1c], total cholesterol [TC], triglycerides [TG]), inflammatory markers (high-sensitivity C-reactive protein [hs-CRP], interleukin-1β/6 [IL-1β/IL-6]), and bone metabolism indicators (osteocalcin [BGP], alkaline phosphatase [ALP], calcitonin [CT]). Data were analyzed using SPSS 24.0. Results: Compared to the conventional group, the HPM group exhibited significantly greater improvements in thyroid function, with more pronounced reductions in FT3 and FT4 (P<0.05) and a greater increase in TSH (P<0.05). Regarding glucose-lipid metabolism, significantly larger decreases in FPG, HbA1c, TC, and TG were identified in the HPM group (P<0.05). Among inflammatory markers, the HPM group showed significant reductions in hs-CRP, IL-1β, IL-6, MIP-1α, and MMP-9 (P<0.05), whereas the conventional group only exhibited improvements in hs-CRP and IL-1β (P<0.05). No significant intergroup differences were observed in bone metabolism parameters (BGP, ALP, CT; P>0.05). Conclusion: The HPM-based intervention, through cognitive restructuring, behavioral modification, and environmental support, effectively enhanced thyroid function, ameliorated glucose-lipid metabolic disturbances, and mitigated chronic inflammation in patients with HT and DM.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: